SCHEMBL8563348

SCHEMBL8563348

COC(=O)c1ccc(NC(=O)Oc2sccc2S(=O)(=O)Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ ALDH1A1 P00352 6/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8563046 0.86 SMN1; SMN2 (0.48) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL27500761 0.80 MAPT (0.53) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL14165763 0.76 LMNA (0.35) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL28151437 0.74 LMNA (0.41) MEN1KMT2AMAPTLMNAPOLB
SCHEMBL28301304 0.72 MAPT (0.37) MEN1KMT2AALDH1A1RAB9AMAPT
SCHEMBL9571061 0.71 LMNA (0.34) MEN1KMT2ALMNATSHR
SCHEMBL8886838 0.70 MEN1 (0.69) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL388034 0.70 MAPT (0.55) MEN1KMT2ANPC1MAPTCYP1A2
SCHEMBL4063113 0.69 TRPV4 (0.42) MAPTLMNA
SCHEMBL8556595 0.68 EDNRA (0.49) ALDH1A1NPC1RAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885219-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-23 — — EP disclosed
WO-1997030996-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 — — WO disclosed
Send feedback